OVS (OVS) Q4 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2026 earnings summary
17 Apr, 2026Executive summary
Achieved record full-year results for FY 2025, with net sales of €1,746 million, up 7.0% year-over-year, driven by strong organic growth, Goldenpoint consolidation, and positive trends across all brands, especially in womenswear and beauty.
Adjusted EBITDA rose 11.7% to €218.2 million, with margin up to 12.5%, and net income increased 14.8% year-over-year.
Cash generation improved 31.2% to €90.0 million, with leverage reduced to 0.7x EBITDA.
Dividend increased by 27% to €0.14 per share, with continued share buybacks and a proposal for further buyback authorization.
Success attributed to the 'house of brands' strategy, with all group brands posting positive figures and strong performance in new segments.
Financial highlights
Net sales reached €1,745.9 million, up 7.0% year-over-year; like-for-like sales grew 2.9%, outperforming the market.
Adjusted EBITDA reached €218.2 million (+€22.9 million), EBITDA margin at 12.5%; gross margin increased by 100 bps to 59.2%.
Net income close to €90 million, up 14.8% year-over-year.
Cash conversion ratio improved to 41.3% of EBITDA; cash flow return on investment reached 26%.
Q4 2025 net sales up 10.1% vs. Q4 2024; EBITDA up 9.7% to €65.8 million.
Outlook and guidance
2026 expected to see further growth in EBITDA and cash generation, supported by favorable EUR/USD rates, ongoing projects, and strong reception of new collections.
Over 100 new stores planned for 2026 across all brands, including OVS, UPIM, Shaka, CROFF, Stefanel, and Goldenpoint.
Women’s segment targeted to reach 40–45% of total sales within 3–4 years.
CapEx for 2026 projected to increase by €10–15 million, mainly for new store openings and refurbishments, especially for Goldenpoint.
Continued buyback plan and international expansion planned for 2026.
Latest events from OVS
- Q1 sales and margins rose, with strong brand momentum and a positive outlook for 2024.OVS
Q1 20253 Feb 2026 - Sales and margins rose in H1 2024, with strong September momentum and positive outlook.OVS
Q2 202520 Jan 2026 - Q3 2024 delivered double-digit sales and EBITDA growth, with robust outlook and share buybacks.OVS
Q3 202511 Jan 2026 - Sales up 6.2%, margins and cash flow improved, with higher dividend and buyback ahead.OVS
Q4 202523 Dec 2025 - Sales and EBITDA up, leverage improved, and outlook remains positive for year-end.OVS
Q3 202618 Dec 2025 - Record sales and profit growth in 1H 2025, with strong outlook and Goldenpoint boost.OVS
Q2 202616 Dec 2025 - Q1 sales grew 0.6% to €354.4m; Goldenpoint synergies and Q2 momentum support a positive outlook.OVS
Q1 202614 Nov 2025